193 related articles for article (PubMed ID: 11041271)
21. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
Kalkman HO; Soar J
Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
[TBL] [Abstract][Full Text] [Related]
22. In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors.
Ahlenius S; Henriksson I; Magnusson O; Salmi P
Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):15-9. PubMed ID: 10082223
[TBL] [Abstract][Full Text] [Related]
23. Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase.
Millan MJ; Newman-Tancredi A; Duqueyroix D; Cussac D
Eur J Pharmacol; 2001 Jul; 424(1):13-7. PubMed ID: 11470255
[TBL] [Abstract][Full Text] [Related]
24. Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.
Martínez-Mota L; Estrada-Camarena E; López-Rubalcava C
Psychopharmacology (Berl); 2002 Dec; 165(1):60-6. PubMed ID: 12474119
[TBL] [Abstract][Full Text] [Related]
25. [Effect of (+/-)-pindolol on the central 5-HT1A receptor by the use of in vivo microdialysis and hippocampal slice preparations].
Tsuji K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Jun; 22(3):85-95. PubMed ID: 12166089
[TBL] [Abstract][Full Text] [Related]
26. Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test.
Bourin M; Redrobe JP; Baker GB
Psychopharmacology (Berl); 1998 Apr; 136(3):226-34. PubMed ID: 9566807
[TBL] [Abstract][Full Text] [Related]
27. Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol.
Rojas-Corrales OM; Ortega-Alvaro A; Gibert-Rahola J; Roca-Vinardell A; Micó JA
Pain; 2000 Nov; 88(2):119-124. PubMed ID: 11050366
[TBL] [Abstract][Full Text] [Related]
28. 5-HT1A receptor antagonists and lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
[TBL] [Abstract][Full Text] [Related]
29. Evidence for specific interactions between 5-HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat.
Wadenberg ML; Cortizo L; Ahlenius S
Pharmacol Biochem Behav; 1994 Mar; 47(3):509-13. PubMed ID: 8208768
[TBL] [Abstract][Full Text] [Related]
30. Evidence for specific involvement of 5-HT1A and 5-HT2A/C receptors in the expression of patterns of spontaneous motor activity of the rat.
Hillegaart V; Estival A; Ahlenius S
Eur J Pharmacol; 1996 Jan; 295(2-3):155-61. PubMed ID: 8720579
[TBL] [Abstract][Full Text] [Related]
31. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1992; 44(2):135-46. PubMed ID: 1357637
[TBL] [Abstract][Full Text] [Related]
32. 5-HT1A-mediated lower lip retraction: effects of 5-HT1A agonists and antagonists.
Moore NA; Rees G; Sanger G; Perrett L
Pharmacol Biochem Behav; 1993 Sep; 46(1):141-3. PubMed ID: 8255903
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
34. Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat.
Ahlenius S; Larsson K; Wijkström A
Eur J Pharmacol; 1991 Aug; 200(2-3):259-66. PubMed ID: 1838333
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the involvement of central 5-HT1A receptors in the mediation of lordosis behavior in the female rat.
Ahlenius S; Larsson K; Fernandez-Guasti A
Psychopharmacology (Berl); 1989; 98(4):440-4. PubMed ID: 2528157
[TBL] [Abstract][Full Text] [Related]
36. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
Johansson L; Sohn D; Thorberg SO; Jackson DM; Kelder D; Larsson LG; Rényi L; Ross SB; Wallsten C; Eriksson H; Hu PS; Jerning E; Mohell N; Westlind-Danielsson A
J Pharmacol Exp Ther; 1997 Oct; 283(1):216-25. PubMed ID: 9336327
[TBL] [Abstract][Full Text] [Related]
37. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
38. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
Chaouloff F; Aguerre S; Mormede P
Neuropharmacology; 1998 Sep; 37(9):1159-67. PubMed ID: 9833646
[TBL] [Abstract][Full Text] [Related]
39. The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats.
Gur E; Newman ME; Avraham Y; Dremencov E; Berry EM
Nutr Neurosci; 2003 Jun; 6(3):169-75. PubMed ID: 12793521
[TBL] [Abstract][Full Text] [Related]
40. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
Gur E; Lerer B; Newman ME
J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
